Internal Medicine
Board Certified in 2019
Hematology
Board Certified in 2022
Oncology
Board Certified in 2022
Internal Medicine
Board Certified in 2019
Hematology
Board Certified in 2022
Oncology
Board Certified in 2022
Bryn Mawr Medical Arts Pavilion
825 Old Lancaster Road
Suite 440
Bryn Mawr, PA 19010
I aim to provide the most cutting edge, evidence-based care to my patients. I combine this with a focus on compassion by individualizing care for every patient and their family’s unique circumstances.
The George Washington University- 2010
Touro College of Osteopathic Medicine- 2016
Main Line Health- Internal Medicine Residency- 2019
Main Line Health- Hematology Oncology Fellowship- 2022
Alliance Cancer Specialists- 2022-2023
ASCO
ASH
PIER Oncology Physician Investigator Advisory Committee
Bloodless Medicine Committee
Blood Transfusion Committee
Research Review Committee- Main Line Health
Sickle Cell Patients Order Review Committee
Dillon, M, Fox E, Zeger E. Peritoneal Carcinomatosis Secondary to Metastatic Testicular Seminoma. Poster presented at: Society of Hospital Medicine – South Central PA Chapter Academic Day and Poster Competition; October 2021; Bethlehem, PA.
Fox E, Kennedy AS, Katz J. Gallbladder Cancer. Medscape Drugs & Diseases. Updated Sept 30, 2021
Fox E, Patel N, Patel A. A Farmer With Diffuse Pruritus and a Suntan That Won’t Fade. Medscape. 2021 June.
Fox E, Oliver T, Vitorsky O, Rowe M, Cohen DA. Bilateral Adrenal Hemorrhage causing Adrenal Insufficiency in the Setting of Antiphospholipid Syndrome. ACP Hospitalist. 2019 May. Online only
Fox E, Oliver T, Rowe M, Gilman P, Thomas S, Muller AJ, Prendergast GC. Indoximod: an immunometabolic adjuvant that empowers T cell activity in cancer. Frontiers in Oncology. 2018 Sep 11;8:370. PMID 30254983
Fox E, Dabrow, M, Ochsner G. A Case of Nivolumab Induced Myositis. Oncologist. 2016 Dec;21(12)e3. Epub 2016 PMID: 27864576
Golovine K, Makhov P, Uzzo RG, Kutikov A, Kaplan DJ, Fox E, Kolenko VM. Cadmium down-regulates expression of XIAP at the post-transcriptional level in prostate cancer cells through an NF-kappaB-independent, proteasome-mediated mechanism. Molecular Cancer. 2010 Jul 9;9:183. PMID 20618956
Crispen PL, Viterbo R, Fox EB, Greenberg RE, Chen DY, Uzzo RG.
Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer. 2008 Mar 1;112(5):1051-7. PMID: 18286513
Rothman J, Crispen PL, Wong YN, Al-Saleem T, Fox E, Uzzo RG. Pathologic Concordance of sporadic synchronous bilateral renal masses. Urology. 2008 Jul;72(1):138-42. Epub 2008 Mar 12. PMID: 18336882
Let’s get started! Answer a few basic questions to see if Jumpstart© with OPTIFAST® Program is right for you.
